HSPA6 and cervical carcinoma: Moreover, hypermethylation of LYPD2 and SHE were associated with poor overall survival (OS); hypermethylation of FGF8 and HSPA6 were associated with poor progression free survival (PFS) in patients with cervical cancer (Figure 5C and 5D).